Related Experiment Video
Updated: May 10, 2026
08:27
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens
Qing-Wen Xu1, Yu Zhang, Xiao-Song Wang
1Department of Immunology; Peking University Health Science Center; Beijing, China.
Oncoimmunology
|June 27, 2013
Abstract:
The effective discovery of tumor-specific antigens (TSAs) holds the key for the development of new diagnostic assays and immunotherapeutic approaches against cancer. Here, we discuss our recently developed technologies, HEPA and PARSE, which allow for the systematic identification of TSAs, generating a reservoir of immunologically and clinically relevant targets.
